The aim of this consultation is to seek the views of stakeholders on proposals for changes to the Medicines and Healthcare products Regulatory Agency’s statutory fees. The consultation will end on Wednesday 23rd November 2022 with the proposed implementation date being 1st April 2023.
The proposed adjustments fall into 3 categories:
- A 10% indexation uplift across statutory fees
- A further uplift for 61 significantly under recovering fees to achieve cost recovery
- The introduction of 22 new fees for services that require cost-recovery since the last fee changes in 2016/2017 for medicines and 2017/2018 for medical device
The consultation document can be read in full here.
Responses are invited on the specific questions raised. The questions can be found through the document and are also listed in full in the below survey.
Please respond through the online consultation survey, on SurveyOptic – SocialOptic.
When responding please say if you are a business, individual or representative body.